Role of endothelin-1 in a syndrome of myelofibrosis and osteosclerosis

3Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Context: Primary myelofibrosis is one of the chronic myeloproliferative disorders characterized by bone marrow fibrosis associated with extramedullary hematopoiesis and osteosclerosis. Endothelin-1 (ET1) is a potent vasoconstrictor that is also a key mediator of osteoblastic bone metastases by stimulating osteoblast proliferation and new bone formation. Case Description:Wereport laboratory, radiographic,bonedensitometry,andbonehistology data of a patient presenting with newly diagnosed, biopsy-proven myelofibrosis and osteosclerosis.We were able to demonstrate abundant ET1 signaling in the bones of our patient. Conclusions: We believe that ET1 is responsible for the osteosclerosis that develops with advanced myelofibrosis and suggest that ET1 signaling may play a role in other osteosclerotic settings as well.

Cite

CITATION STYLE

APA

Yachoui, R., Kristianto, J., Sitwala, K., & Blank, R. D. (2015). Role of endothelin-1 in a syndrome of myelofibrosis and osteosclerosis. Journal of Clinical Endocrinology and Metabolism, 100(11), 3971–3974. https://doi.org/10.1210/jc.2015-2729

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free